TY - JOUR
T1 - Current therapy of chronic myelogenous leukemia
AU - McGlave, P.
PY - 1998
Y1 - 1998
N2 - Numerous approaches to CML therapy are now available which promise prolonged remission and, in some cases, cure. What is now needed is a cohesive, integrated and step-wise approach to CML patients providing low-risk therapy when possible, but without jeopardizing the opportunity for cure. Several studies are underway which examine this issue.
AB - Numerous approaches to CML therapy are now available which promise prolonged remission and, in some cases, cure. What is now needed is a cohesive, integrated and step-wise approach to CML patients providing low-risk therapy when possible, but without jeopardizing the opportunity for cure. Several studies are underway which examine this issue.
UR - http://www.scopus.com/inward/record.url?scp=0031739824&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031739824&partnerID=8YFLogxK
U2 - 10.3109/10428199809058619
DO - 10.3109/10428199809058619
M3 - Article
AN - SCOPUS:0031739824
SN - 1042-8194
VL - 30
SP - 20
EP - 21
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
IS - SUPPL. 1
ER -
